Cite
HARVARD Citation
Hørslev-Petersen, K. et al. (n.d.). FRI0148 Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). Annals of the rheumatic diseases. pp. 360-361. [Online].